Fingerprint Fingerprint is based on mining the text of the persons scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 11 Similar Profiles
Opiate Alkaloids Medicine & Life Sciences
Methadone Medicine & Life Sciences
Buprenorphine Medicine & Life Sciences
Opioid Analgesics Medicine & Life Sciences
Naltrexone Medicine & Life Sciences
Cocaine Medicine & Life Sciences
Cocaine-Related Disorders Medicine & Life Sciences
Heroin Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1995 2017

  • 42 Article
  • 1 Conference contribution

Effects of incentives for naltrexone adherence on opiate abstinence in heroin-dependent adults

Jarvis, B. P., Holtyn, A. F., Defulio, A., Dunn, K. E., Everly, J. J., Leoutsakos, J. M. S., Umbricht, A., Fingerhood, M., Bigelow, G. E. & Silverman, K. 2017 (Accepted/In press) In : Addiction.

Research output: Contribution to journalArticle

Opiate Alkaloids
Naltrexone
Heroin
Motivation
Cocaine
Opiate Alkaloids
Naltrexone
Heroin
Cocaine
Self Report

Predictors of induction onto extended-release naltrexone among unemployed heroin-dependent adults

Jarvis, B. P., Holtyn, A. F., Berry, M. S., Subramaniam, S., Umbricht, A., Fingerhood, M., Bigelow, G. E. & Silverman, K. Sep 30 2016 (Accepted/In press) In : Journal of Substance Abuse Treatment.

Research output: Contribution to journalArticle

Naltrexone
Heroin
Opioid Analgesics
Salaries and Fringe Benefits
Workplace

Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial

Griffiths, R. R., Johnson, M. W., Carducci, M. A., Umbricht, A., Richards, W. A., Richards, B. D., Cosimano, M. P. & Klinedinst, M. A. Dec 1 2016 In : Journal of Psychopharmacology. 30, 12, p. 1181-1197 17 p.

Research output: Contribution to journalArticle

Psilocybin
Anxiety
Depression
Neoplasms
Spirituality

Zonisamide Reduces withdrawal symptoms but does not enhance varenicline-induced smoking cessation

Dunn, K. E., Marcus, T. F., Pharm, C. K., Schroeder, J. R., Vandrey, R. & Umbricht, A. May 1 2016 In : Nicotine and Tobacco Research. 18, 5, p. 1171-1179 9 p., ntv144

Research output: Contribution to journalArticle

zonisamide
Substance Withdrawal Syndrome
Smoking Cessation
Nicotine
Smoking